Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00781677 · ClinicalTrials.gov registry record
Using Neuroimaging to Investigate Major Depressive Disorder
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 14
- Enrollment target
NCT00781677: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT00781677 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00781677 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The purpose of this neuroimaging study is to investigate the brain correlates of Major Depressive Disorder with anxiety symptoms as well as potentially identify predictors of treatment outcome.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2008-05 |
| Est. Completion | 2011-01-20 |
What the finished NCT00781677 record still lists
NCT00781677 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00781677 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00781677 about?
NCT00781677 is a clinical study titled "Using Neuroimaging to Investigate Major Depressive Disorder". The purpose of this neuroimaging study is to investigate the brain correlates of Major Depressive Disorder with anxiety symptoms as well as potentially identify predictors of treatment outcome.
What is the current status of trial NCT00781677?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2008-05. Estimated completion is 2011-01-20.
Who is sponsoring clinical trial NCT00781677?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia